Amcure GmbH
Records under this name other than patents Amcure GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Amcure GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,703,796 | CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,593,146 | CD44v6-derived peptides for treating metastasizing cancer Lapsed on the fee record Ended Mar 14, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 14, 2025 | USPTO record |
| US 9,586,993 | CD44v6-derived peptides for treating pancreatic cancer Lapsed on the fee record Ended Mar 7, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 7, 2025 | USPTO record |
| US 9,586,994 | CD44V6-derived peptides for treating breast cancer Lapsed on the fee record Ended Mar 7, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 7, 2025 | USPTO record |